Community Pharmacy Scotland announces first part of funding deal for 2025/2026 Under the funding deal accepted by Community Pharmacy Scotland, in 2025/2026, the guaranteed minimum for reimbursement will increase to £120m.…
Monoclonal antibody ‘critical intervention’ for preventing infant RSV, study suggests Researchers found that nirsevimab reduced hospitalisations caused by respiratory syncytial virus in infants by more than 80%.…
Pancreatic exocrine insufficiency: causes, diagnosis and treatment An overview of the causes, diagnosis and treatments for pancreatic exocrine insufficiency, including a case study of a patient’s experience.…
Hub-and-spoke dispensing expansion set to begin in October 2025 Hub-and-spoke dispensing between different legal entities will be permitted from 1 October 2025 under draft amendments to the Human Medicines Regulations 2012.…
New antibiotic already causing AMR concerns, study results suggest Researchers also found that ceftazidime with avibactam-resistant bacteria coincided with the presence of carbapenemase genes.…
Share your experience: tell us about your salary and working conditions Calling all pharmacists! Please take part in our short survey, which should take no more than ten minutes to complete.…
Medicines optimisation teams need to showcase their value to withstand ICB funding cuts With integrated care boards soon to have lost 65% of their funding over two years, now is the time for medicines optimisation teams to ‘be noisy’ about their work.…
